Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Biotech

+ Watchlist
BBBIOEB:LX
401.45
EUR
15.75
3.78%
As of 8:40 AM EST on 2/11/2016.
Fund Type
SICAV
52Wk Range
401.45 - 721.72
1 Yr Return
-30.81%
YTD Return
-33.33%
Previous Close
417.20
52Wk Range
401.45 - 721.72
1 Yr Return
-30.08%
YTD Return
-33.33%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 02/11/2016)
401.45
Total Assets (m USD) (on 02/11/2016)
60.607
Inception Date
04/02/2009
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
CHRISTIAN LACH
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
2.32%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 24.20 k 7.41 m 8.30
Celgene Corp 60.00 k 7.19 m 8.04
Regeneron Pharmaceuticals Inc 13.00 k 7.06 m 7.90
Gilead Sciences Inc 62.00 k 6.27 m 7.02
Amgen Inc 38.00 k 6.17 m 6.91
Mylan NV 70.00 k 3.78 m 4.24
Illumina Inc 19.30 k 3.70 m 4.15
Alexion Pharmaceuticals Inc 18.40 k 3.51 m 3.93
Vertex Pharmaceuticals Inc 25.00 k 3.15 m 3.52
Incyte Corp 29.00 k 3.15 m 3.52
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00